The urogenital microbiota is dominated by Lactobacillus that, together with Bifidobacterium, creates a physiological barrier counteracting pathogen infections. The aim of this study was to evaluate the efficacy of a multi-strain probiotic formulation (Lactiplantibacillus plantarum PBS067, Lacticaseibacillus rhamnosus LRH020, and Bifidobacterium animalis subsp. lactis BL050) to inhibit adhesion and growth of urogenital pathogens. The antimicrobial and antiadhesive properties of the probiotic strains and their mixture were evaluated on human vaginal epithelium infected with Candida glabrata, Neisseria gonorrheae, Trichomonas vaginalis, and Escherichia coli-infected human bladder epithelium. The epithelial tissue permeability and integrity were assessed by transepithelial/transendothelial electrical resistance (TEER). Co-aggregation between probiotics and vaginal pathogens was also investigated to elucidate a possible mechanism of action. The multi-strain formulation showed a full inhibition of T. vaginalis, and a reduction in C. glabrata and N. gonorrheae growth. A relevant antimicrobial activity was observed for each single strain against E. coli. TEER results demonstrated that none of the strains have negatively impaired the integrity of the 3D tissues. All the probiotics and their mixture were able to form aggregates with the tested pathogens. The study demonstrated that the three strains and their mixture are effective to prevent urogenital infections.
Skin is constantly exposed to UV radiation. While topical sunscreens are the main preventative measure, oral photoprotective agents are emerging as promising systemic adjuncts, offering uniform, continuous protection. This study presents the results of two clinical trials designed to evaluate the efficacy of supplementation with a standardized coriander (Coriandrum sativum L.) seed oil (CSO) in mitigating UV-induced skin damage, in comparison with a placebo. The first trial investigated the effects of CSO supplementation on women with reactive skin, assessing UVA+B-induced skin erythema and tumor necrosis factor-alpha (TNF-α) release. The second trial included women of all skin types and, in addition to the outcomes mentioned above, examined UVA-induced lipoperoxidation. Measurements were taken before and after 56 days of supplementation. CSO supplementation led to a significant reduction in UV-induced skin erythema and associated TNF-α levels in both cohorts, with decreases of 11.8% and 24.1% in the reactive skin group and 18.1% and 18.7% in the cohort with all skin types, respectively. In women of all skin types, UV-induced skin lipoperoxidation was reduced by 31.9% at 4 h and by 69.9% at 24 h post-exposure. To the best of our knowledge, this is the first study reporting the photoprotective efficacy of CSO. This finding is attributed to CSO’s high petroselinic acid content and its known anti-inflammatory properties.